Cargando…
Extracorporeal Shock Wave Treatment (ESWT) enhances the in vitro-induced differentiation of human tendon-derived stem/progenitor cells (hTSPCs)
Extracorporeal shock wave therapy (ESWT) is a non-invasive and innovative technology for the management of specific tendinopathies. In order to elucidate the ESWT-mediated clinical benefits, human Tendon-derived Stem/Progenitor cells (hTSPCs) explanted from 5 healthy semitendinosus (ST) and 5 ruptur...
Autores principales: | Leone, Laura, Raffa, Salvatore, Vetrano, Mario, Ranieri, Danilo, Malisan, Florence, Scrofani, Cristina, Vulpiani, Maria Chiara, Ferretti, Andrea, Torrisi, Maria Rosaria, Visco, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872723/ https://www.ncbi.nlm.nih.gov/pubmed/26843618 http://dx.doi.org/10.18632/oncotarget.7064 |
Ejemplares similares
-
Extracorporeal Shock Wave Treatment (ESWT) Improves In Vitro Functional Activities of Ruptured Human Tendon-Derived Tenocytes
por: Leone, Laura, et al.
Publicado: (2012) -
Hyaluronic Acid (HA), Platelet-Rich Plasm and Extracorporeal Shock Wave Therapy (ESWT) promote human chondrocyte regeneration in vitro and ESWT-mediated increase of CD44 expression enhances their susceptibility to HA treatment
por: Vetrano, Mario, et al.
Publicado: (2019) -
Chronic heart failure is characterized by altered mitochondrial function and structure in circulating leucocytes
por: Coluccia, Roberta, et al.
Publicado: (2018) -
Different culture conditions affect the growth of human tendon stem/progenitor cells (TSPCs) within a mixed tendon cells (TCs) population
por: Viganò, M., et al.
Publicado: (2017) -
Cholesteatoma-associated fibroblasts modulate epithelial growth and differentiation through KGF/FGF7 secretion
por: Raffa, Salvatore, et al.
Publicado: (2012)